ACR/ARHP 2017: New Analysis Shows Rheumatoid Arthritis Patients Treated with Baricitinib Reported Greater Improvements in Pain Compared to Adalimumab or Placebo
WMBF News,
SOURCE Eli Lilly and Company - Post-hoc analysis presented at ACR/ARHP shows pain improvement was consistent regardless of a…